Weight loss injections primarily refer to glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Wegovy), tirzepatide (Zepbound), and liraglutide (Saxenda)
Studies using FDA adverse event data found elevated reporting odds ratios for alopecia with semaglutide at 2.46 and tirzepatide at 1.73
MADE IN EUROPE following the strictest quality and safety controls
Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges
We found that GLP-1 RA use was associated with significant improvement in RA disease activity, pain, and cardiovascular risk profile
PCOS often involves insulin resistance, anovulation, and elevated androgen levels (such as testosterone), all of which interfere with the normal hormonal signals required for ovulation and conception